![]() | This article has multiple issues. Please help improve it or discuss these issues on the talk page . (Learn how and when to remove these messages)
|
![]() | |
Type | News and analysis service |
---|---|
Format | Daily online |
Owner(s) | Citeline |
Publisher | Philip Jarvis |
Founded | March 1972 |
Headquarters | London, England |
Website | www.scripnews.com |
Scrip Intelligence (Scrip) is an English language international pharmaceutical news, analysis and data service. First published as a weekly print newsletter in March 1972, Scrip included articles on side-effects, regulatory changes and mergers and acquisitions.
Scrip World Pharmaceutical News was initially published by advertising company J Walter Thomson but was bought by Dr Philip J Brown in 1976 for £2000, who founded PJB Publishing. Brown sold Scrip, associated titles, and his company to Informa for £150 million in 2003. [1] [2] [3]
Scrip has now developed into an online global pharma news and analysis service. It provides daily news and analysis on the biotechnology and pharmaceutical industry including areas such as policy & regulation, business news, research & development, generics, drug delivery, and clinical trials.
In 2022, Informa sold its Pharma Intelligence division, including Scrip, to Warburg Pincus. [4] The business was renamed Citeline. Later in 2022, Citeline was acquired by Norstella. [5]
The Scrip readership has grown to over 100,000 worldwide, [6] half of which are in Europe. Scrip is read by managers and executives working across all disciplines in pharmaceutical and biotech companies worldwide. [7]
Scrip has a large independent editorial team of 21. The journalists are based throughout the world in Washington, D.C., Tokyo, India, and London to ensure a global emphasis to the latest news stories.